KATHRYN CAMERON: Open Payments
NPI 1700877081 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,155 in 77 payments from 20 companies in 2025. Trend: 2023 $48 · 2024 $166 · 2025 $2,155
Food & beverage: $2,075Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $547 |
| Amgen Inc. | 12 | $284 |
| Regeneron Healthcare Solutions, Inc. | 7 | $215 |
| Boston Scientific Corporation | 2 | $212 |
| GlaxoSmithKline, LLC. | 9 | $186 |
| 3B Medical, Inc. | 2 | $95 |
| Insmed, Inc. | 3 | $80 |
| Viatris Specialty LLC | 4 | $72 |
| Verona Pharma, Inc. | 3 | $64 |
| JAZZ PHARMACEUTICALS INC. | 2 | $61 |
Products named: TEZSPIRE, DUPIXENT, AMS 700, FASENRA, TRELEGY ELLIPTA, BREZTRI, LUNA, Arikayce.
Industry payments across VA — which companies pay providers there.
